Open-label, multiple-dose escalation study of PTC-299 in Healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2016
At a glance
- Drugs PTC 299 (Primary)
- Indications Breast cancer; CNS cancer; Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors PTC Therapeutics
- 01 Jul 2016 Results published in the Clinical Pharmacology in Drug Development
- 28 May 2007 Results data have been reported.
- 04 Dec 2006 Checked against 1054820.